insights_auto
Varför har CMPS gått upp 3,35%?
Gå på djupetchevron_right
CMPS:NASDAQ
Compass Pathways PLC
11,11 US$
arrow_upward
+3,35%(+0,36) 1 d
19 okt., 15:32:05 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för CMPS …
Öppen
10,87 US$
Högt
11,12 US$
Lågt
10,81 US$
Börsvärde
1,54 md
Genomsn. vol.
2,94 mn
Volym
1,51 mn
52v högst
15,87 US$
52v lägst
4,88 US$
EPS
−3,47 US$
Beta
2,55
Utestående aktier
138,48 mn
Antal anställda
156
Öppen
10,87 US$
Högt
11,12 US$
Lågt
10,81 US$
Börsvärde
1,54 md
Genomsn. vol.
2,94 mn
Volym
1,51 mn
52v högst
15,87 US$
52v lägst
4,88 US$
EPS
−3,47 US$
Beta
2,55
Utestående aktier
138,48 mn
Antal anställda
156
Nyheter och artiklar
Från webbkällor och nyhetspartner
Simply Wall Street
·
för 20 timmar sedan
Phase 3 Trial Success Might Change The Case For COMPASS Pathways Stock
Yahoo Finance
·
för 1 dag sedan
COMPASS Pathways (CMPS) Stock May Trade At A Premium After Positive Phase 3 Results
Profil
Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin, has completed phase 3 clinical trials for treatment-resistant depression. The results showed clear benefit to participants as measured on the MADRS depression rating scale. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration. It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine.
Compass Pathways is the largest company in the psychedelic medicine industry and, in 2020, was the first psychedelic medicine company to be listed on the NASDAQ. It has faced criticism for patenting psychedelic drugs and even certain psilocybin mushroom species. In October 2024, after the FDA rejected Lykos Therapeutics's MDMA for post-traumatic stress disorder New Drug Application, Compass Pathways said that it would lay off 30% of its workforce and narrow its research focus. Wikipedia
Om Compass Pathways PLC